Sir Run Run Shaw Hospital

People's Republic of China

Country: People's Republic of China

Ownership: Private

Established: 1994-01-01

Employees: -

Market Cap: -

Website: http://www.srrsh.com/html/main/gb2312/

Clinical Trials

Heterogeneity of Lung Ventilation Determined by EIT During PFT in Patients With PRISM

Recruiting

Conditions: COPD

Interventions: Diagnostic Test: pulmonary function test

First Posted Date: 2024-01-10

Last Posted Date: 2024-05-08

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 200

Registration Number: NCT06199258

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer

Not Applicable

Recruiting

Conditions: Colorectal Cancer

Interventions: Diagnostic Test: standard treatment
Diagnostic Test: ctDNA methylation

First Posted Date: 2023-12-13

Last Posted Date: 2024-05-17

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 990

Registration Number: NCT06167967

Locations: 🇨🇳
Sir Run Run Shao hospital, Hanzhou, Zhejiang, China

Comparison of Clinical Outcomes of Mini Midline Catheters With Different Placement Sites: a Randomized Controlled Trial

Not Applicable

Completed

Conditions: Catheter Complications

Interventions: Device: Mini Midline

First Posted Date: 2023-10-30

Last Posted Date: 2024-04-11

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 130

Registration Number: NCT06106659

Locations: 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China

Molecular Basis of Loss Aversion

Not Applicable

Recruiting

Conditions: Healthy

Interventions: Drug: single-dose madopar, single-dose placebo, and single-dose propranolol by order
Drug: single-dose propranolol, single-dose madopar, and single-dose placebo by order
Drug: single-dose propranolol, single-dose placebo, and single-dose madopar by order
Drug: single-dose placebo, single-dose propranolol, and single-dose madopar by order
Drug: single-dose madopar, single-dose propranolol, and single-dose placebo by order
Drug: single-dose placebo, single-dose madopar, and single-dose propranolol by order

First Posted Date: 2023-09-13

Last Posted Date: 2023-09-26

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 60

Registration Number: NCT06034158

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

An Exploratory Study of Perioperative Venous Access in Obese Patients

Not Applicable

Not yet recruiting

Conditions: Catheter Complications

Interventions: Other: Midline catheter
Other: Long peripheral venous catheters for use

First Posted Date: 2023-09-11

Last Posted Date: 2023-09-11

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 528

Registration Number: NCT06031545

Locations: 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms

Phase 1

Recruiting

Conditions: Digestive System Neoplasms

Interventions: Biological: iNeo-Vac-R01 in combination with standard adjuvant therapy

First Posted Date: 2023-09-07

Last Posted Date: 2023-09-11

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 20

Registration Number: NCT06026774

Locations: 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms

Phase 1

Recruiting

Conditions: Digestive System Neoplasms

Interventions: Biological: iNeo-Vac-R01

First Posted Date: 2023-09-07

Last Posted Date: 2023-09-11

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 20

Registration Number: NCT06026800

Locations: 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms

Phase 1

Recruiting

Conditions: Digestive System Neoplasms

Interventions: Biological: iNeo-Vac-R01

First Posted Date: 2023-08-31

Last Posted Date: 2023-09-11

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 20

Registration Number: NCT06019702

Locations: 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Research on the Application of Blood Collection Through Midline Catheters of Different Lengths

Not Applicable

Not yet recruiting

Conditions: Catheter Complications

Interventions: Behavioral: Midline catheter for blood collection
Behavioral: Long peripheral venous catheters for blood collection
Behavioral: SPCs for blood collection

First Posted Date: 2023-08-28

Last Posted Date: 2023-10-25

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 162

Registration Number: NCT06014099

Locations: 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

Phase 2

Recruiting

Conditions: Low Rectal Cancer

Interventions: Radiation: Modified short-course radiotherapy
Drug: PD-1 antibody
Drug: Capecitabine
Drug: Oxaliplatin

First Posted Date: 2023-08-02

Last Posted Date: 2024-05-10

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 32

Registration Number: NCT05972655

Locations: 🇨🇳
Sir Run Run Shao hospital, Hanzhou, Zhejiang, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy